Nine companies receive matching funds from the state
January 25, 2010
Through the SBIR-STTR matching funds program:
Four Tigers, near Paris, is developing blackberry-based cosmetics, dietary supplements, food and medical products that offer the fruit’s potent anti-inflammatory and antioxidant properties.
www.four-tigers.com
NaugaNeedles, of Louisville, produces nano-scale probes and electrodes for use in mechanical, electrical, and electrochemical sensing and manipulation at cellular and molecular levels.
www.nauganeedles.com
SCR, of Louisville, is developing a long-term implantable counterpulsation medical device to treat heart failure patients who may be responsive to a moderate level of cardiac assistance.
www.scrdevelopmentgroup.com
Topasol, of Lexington, produces nanoparticles for use in new coatings and composites for sensors, biocides, mar-resistant materials, optical devices, solar cells and colorings.
www.topasol.com
Transposagen, of Lexington, uses mobile DNA technology (transposons) to develop genetically modified laboratory rats that can mimic human diseases and be used for medical research.
www.transposagenbio.com
ApoImmune, of Louisville, is developing vaccines to treat cancer and prevent infectious diseases, as well as therapies to improve patient tolerance to transplanted organs and cells.
www.apoimmune.com
NuForm Materials, near Georgetown, makes ceramic materials for use in automotive and aerospace composites that can help lower cost and improve performance and fuel efficiency.
www.nuformmaterials.com
PGxl Laboratories, of Louisville, is studying how genetics affect the way patients react to medicines to help physicians select drugs and adjust dosages to avoid adverse drug reactions.
www.pgxlab.com
3H Company, of Lexington, is focusing on clean coal technology and testing its carbon sequestration technology designed to capture and store carbon dioxide underground.
